Editas Medicine, Inc.
CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING HERPES SIMPLEX VIRUS
Last updated:
Abstract:
CRISPR/CAS-related systems, compositions and methods for editing RS1, RL2, and/or LAT genes in human cells are described, as are cells and compositions including cells edited according to the same.
Status:
Application
Type:
Utility
Filling date:
19 Apr 2021
Issue date:
13 Jan 2022